会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • P62 AS A RISK DETERMINANT FOR METABOLIC SYNDROME
    • P62作为代谢综合征的风险决定因素
    • WO2007044522A1
    • 2007-04-19
    • PCT/US2006/039151
    • 2006-10-05
    • AUBURN UNIVERSITYWOOTEN, Marie, W.DIAZ-MECO, Maria, T.MOSCAT, Jorge
    • WOOTEN, Marie, W.DIAZ-MECO, Maria, T.MOSCAT, Jorge
    • G01N33/68A61K38/16
    • A61K38/1709G01N33/6896G01N2800/2814G01N2800/2835
    • The p62 protein has been analyzed and identified as the significant contributor to several metabolic pathways that lead to metabolic syndrome, Alzheimer's Disease, and other related diseases. The absence of the p62 protein has a profound effect on the accumulation of tau protein, amyloid beta protein and an increase in blood insulin levels. The accumulation of tau protein and amyloid beta protein in neurological tissues is a hallmark of neurological metabolic diseases such as Alzheimer's Disease and related dementias. Moreover, increase blood insulin levels is an indicator of insulin resistance in mammals. Accordingly, the present invention provides a method for screening a mammal for metabolic disease comprising the step of detecting the absence of the p62 protein. The present invention also contemplates a method of screening a mammal for a metabolic syndrome comprising the steps of detecting the level of p62 protein in a metabolic pathway and determining whether the level of p62 protein falls below a threshold level. A pharmaceutical composition is also contemplated for therapeutic supplementation of a metabolic pathway, the pharmaceutical composition comprising a p62 protein or an amide, ester or salt thereof and a pharmaceutically effective carrier. Such pharmaceutical composition will have an inhibitory action on the phosphorylation, ubiquitination, accumulation of tau protein, an inhibitory effect on the accumulation of APP/amyloid beta and may operate to lower blood insulin levels.
    • p62蛋白已被分析并确定为导致代谢综合征,阿尔茨海默病和其他相关疾病的几种代谢途径的重要贡献者。 p62蛋白的缺失对tau蛋白,淀粉样蛋白β蛋白的积累和血液胰岛素水平的增加具有深远的影响。 tau蛋白和淀粉样β蛋白在神经组织中的积累是神经代谢疾病如阿尔茨海默病和相关痴呆的标志。 此外,增加血液胰岛素水平是哺乳动物胰岛素抵抗的指标。 因此,本发明提供了筛选哺乳动物代谢疾病的方法,包括检测p62蛋白不存在的步骤。 本发明还考虑了筛选哺乳动物代谢综合征的方法,其包括以下步骤:检测代谢途径中p62蛋白的水平并确定p62蛋白的水平是否低于阈值水平。 还考虑药物组合物用于治疗性补充代谢途径,所述药物组合物包含p62蛋白或其酰胺,酯或其盐和药学上有效的载体。 这种药物组合物将对磷酸化,泛素化,tau蛋白的积累,对APP /淀粉样蛋白β的积累的抑制作用具有抑制作用并且可以降低血液胰岛素水平。